CytoSorb® in Patients With Acute on Chronic Liver Failure
Condition(s):Acute on Chronic Liver Failure; Alcoholic HepatitisLast Updated:November 29, 2022Withdrawn
Hide Studies Not Open or Pending
Condition(s):Acute on Chronic Liver Failure; Alcoholic HepatitisLast Updated:November 29, 2022Withdrawn
Condition(s):Septic ShockLast Updated:January 18, 2024Recruiting
Condition(s):Acute Coronary SyndromeLast Updated:February 4, 2022Terminated
Condition(s):Acute-On-Chronic Liver Failure; Anticoagulant Adverse Reaction; Sarcopenia; UltrasonographyLast Updated:February 29, 2024Not yet recruiting
Condition(s):Aneurysmal Subarachnoid HaemorrhageLast Updated:August 8, 2022Terminated
Condition(s):Septic Shock; Cytokine StormLast Updated:June 10, 2021Completed
Condition(s):Sepsis; Immune Deficiency; Hemoperfusion; Blood PurificationLast Updated:December 22, 2022Completed
Condition(s):COVID-19Last Updated:February 9, 2024Completed
Condition(s):Pancreatitis, Acute; SIRSLast Updated:March 17, 2017Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.